eBioscience Private
eBioscience is a leading research and diagnostic company specializing in immunology and oncology flow cytometry reagents. With a wide range of antibodies, ELISAs, and proteins, eBioscience offers one of the largest selections of reagents for life science research and diagnostics. They are known for their comprehensive and innovative portfolio of products for immunology, oncology, cell biology, stem cell biology, and diagnostics. eBioscience is also recognized for being the first to market with critical reagents, developing over 800 new products for multicolor flow cytometry every year.
Headquarters:
United States
Total Funding:
$55M
Founded Date:
2009
Investors Number:
1
Estimated Revenue:
$10M to $50M
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
MarketPlace
Employee Number:
1K
Industry:
Stem Cells (Regenerative Medicine)
Last Funding Type:
Venture - Series Unknown
Funding Status:
M&A